Global ECMO Devices Market to Reach US$ 306.4 Million by 2029 Driven by VV ECMO and Adult Patient Demand

ECMO Devices Market Size

The global ECMO Devices revenue was US$ 236.9 million in 2022 and is forecast to a readjusted size of US$ 306.4 million by 2029 with a CAGR of 3.7% during the forecast period (2023-2029).

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-15G16268/Global_and_India_ECMO_Devices_Market_Report_Forecast_2023_2029

Major Trends
VV ECMO surges for respiratory support, adults lead from chronic disease prevalence.
• VV ECMO dominates for lung failure, ARDS management.
• Adult segment grows with cardiac, pulmonary comorbidities.
• VA ECMO supports heart-lung bypass in shock cases.
• Portable units enable inter-hospital transfers.

Trends Influencing the Growth of the Global ECMO Devices - Global Market

VV (Veno-Venous) ECMO commands type segment growth, delivering respiratory support by oxygenating blood and removing CO2 without direct cardiac assist, ideal for isolated lung failure in ARDS, pneumonia, or trauma. Dual-lumen cannulation simplifies access via internal jugular, minimizing recirculation while preserving native heart function, which suits prolonged ventilation weaning. Centrifugal pumps with silicone oxygenators reduce hemolysis and clot risks through low-shear paths and heparin coatings, enabling safer extended runs. This modality expands market reach as protocols favor early intervention, improving survival in non-surgical respiratory distress.

Adult end users propel market development, driven by rising acute respiratory distress and post-cardiotomy needs in mature healthcare systems with high ICU capacities. Aging demographics amplify demand for bridge-to-recovery or transplant support amid comorbidities like COPD and sepsis, where conventional ventilation fails. Mobile ECMO teams facilitate rapid deployment in ERs, while data from ELSO registries validate outcomes, encouraging investment. Integration with VADS in hybrid procedures further cements adults as primary volume drivers globally.

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-15G16268/global-and-india-ecmo-devices

By Type
• VA (Veno-Arterial) ECMO
• VV (Veno-Venous) ECMO

By Application
• Adult
• Neonatal
• Pediatric

Key Companies
Medtronic, Getinge (Maquet), LivaNova (Sorin), Terumo, Fresenius Medical Care

Market Share:
North America leads with infrastructure, Asia-Pacific grows fastest via capacity builds.

Purchase Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-15G16268/Global_and_India_ECMO_Devices_Market_Report_Forecast_2023_2029

Email Id:
Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains detail research methodology employed to generate the report, Please also reach to our sales team to get the complete list of our data sources

This release was published on openPR.